{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:26:30Z","timestamp":1793413590925,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T00:00:00Z","timestamp":1620864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T00:00:00Z","timestamp":1620864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Isolated rapid eye movement (REM) sleep behavior disorder (iRBD) is a prodromal stage of Lewy-type synucleinopathies (LTS), which can present either with an initial predominant parkinsonism (Parkinson\u2019s disease (PD)) or dementia (dementia with Lewy bodies (DLB)). To provide insights into the underlying pathogenic mechanisms, the lipoprotein and protein glycosylation profile of 82 iRBD patients, collected before and\/or after their conversion to an overt LTS, and 29 matched control serum samples were assessed by nuclear magnetic resonance (NMR) spectroscopy. Data were statistically analyzed to identify altered metabolites and construct predictive models. Univariant analysis detected no differences between iRBD patients with an LTS compared to controls. However, significant differences were found when the analysis distinguished between iRBD patients that manifested initially predominant parkinsonism (pre-PD) or dementia (pre-DLB). Significant differences were also found in the analysis of paired iRBD samples pre- and post-LTS diagnosis. Predictive models were built and distinguished between controls and pre-DLB patients, and between pre-DLB and pre-PD patients. This allowed a prediction of the possible future clinical outcome of iRBD patients. We provide evidence of altered lipoprotein and glycosylation profiles in subgroups of iRBD patients. Our results indicate that metabolic alterations and inflammation are involved in iRBD pathophysiology, and suggest biological differences underlying the progression of LTS in iRBD patients. Our data also indicate that profiling of serum samples by NMR may be a useful tool for identifying short-term high-risk iRBD patients for conversion to parkinsonism or dementia.<\/jats:p>","DOI":"10.1038\/s41531-021-00184-9","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T10:03:16Z","timestamp":1620900196000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Serum metabolic biomarkers for synucleinopathy conversion in isolated REM sleep behavior disorder"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9732-6677","authenticated-orcid":false,"given":"Ariadna","family":"Laguna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6641-1222","authenticated-orcid":false,"given":"Helena","family":"Xicoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Tolosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f2nica","family":"Serradell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Vilas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles","family":"Gaig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Yanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Santamaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Amig\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Iranzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1352-989X","authenticated-orcid":false,"given":"Miquel","family":"Vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,13]]},"reference":[{"key":"184_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes, A. J., Daniel, S. E., Kilford, L. & Lees, A. J. Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 55, 181\u2013184 (1992).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"184_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith, I. G. et al. Diagnosis and management of dementia with Lewy bodies. Neurology 89, 88\u2013100 (2017).","journal-title":"Neurology"},{"key":"184_CR3","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S1474-4422(16)00057-0","volume":"15","author":"A Iranzo","year":"2016","unstructured":"Iranzo, A., Santamaria, J. & Tolosa, E. Idiopathic rapid eye movement sleep behaviour disorder: diagnosis, management, and the need for neuroprotective interventions. Lancet Neurol. 15, 405\u2013419 (2016).","journal-title":"Lancet Neurol."},{"key":"184_CR4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nrneurol.2017.157","volume":"14","author":"B H\u00f6gl","year":"2018","unstructured":"H\u00f6gl, B., Stefani, A. & Videnovic, A. Idiopathic REM sleep behaviour disorder and neurodegeneration\u2014an update. Nat. Rev. Neurol. 14, 40\u201355 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"184_CR5","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S1474-4422(13)70056-5","volume":"12","author":"A Iranzo","year":"2013","unstructured":"Iranzo, A. et al. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol. 12, 443\u2013453 (2013).","journal-title":"Lancet Neurol."},{"key":"184_CR6","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/brain\/awz030","volume":"142","author":"RB Postuma","year":"2019","unstructured":"Postuma, R. B. et al. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain 142, 744\u2013759 (2019).","journal-title":"Brain"},{"key":"184_CR7","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/mds.27802","volume":"34","author":"S Heinzel","year":"2019","unstructured":"Heinzel, S. et al. Update of the MDS research criteria for prodromal Parkinson\u2019s disease. Mov. Disord. 34, 1464\u20131470 (2019).","journal-title":"Mov. Disord."},{"key":"184_CR8","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1212\/WNL.0000000000002414","volume":"86","author":"JC Wong","year":"2016","unstructured":"Wong, J. C. et al. Risk factors for probable REM sleep behavior disorder. Neurology 86, 1306\u20131312 (2016).","journal-title":"Neurology"},{"key":"184_CR9","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1212\/WNL.0000000000003902","volume":"88","author":"C Ma","year":"2017","unstructured":"Ma, C. et al. Probable REM sleep behavior disorder and risk of stroke. Neurology 88, 1849\u20131855 (2017).","journal-title":"Neurology"},{"key":"184_CR10","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1212\/WNL.0000000000000247","volume":"82","author":"B Frauscher","year":"2014","unstructured":"Frauscher, B. et al. Comorbidity and medication in REM sleep behavior disorder: a multicenter case-control study. Neurology 82, 1076\u20131079 (2014).","journal-title":"Neurology"},{"key":"184_CR11","doi-asserted-by":"publisher","first-page":"e75743","DOI":"10.1371\/journal.pone.0075743","volume":"8","author":"Q Wei","year":"2013","unstructured":"Wei, Q. et al. Reduced serum levels of triglyceride, very low density lipoprotein cholesterol and apolipoprotein B in Parkinson\u2019s disease patients. PLoS ONE 8, e75743 (2013).","journal-title":"PLoS ONE"},{"key":"184_CR12","doi-asserted-by":"publisher","first-page":"e1710","DOI":"10.1212\/WNL.0000000000006439","volume":"91","author":"S Mondello","year":"2018","unstructured":"Mondello, S. et al. Novel biomarker signatures for idiopathic REM sleep behavior disorder: a proteomic and system biology approach. Neurology 91, e1710\u2013e1715 (2018).","journal-title":"Neurology"},{"key":"184_CR13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jocn.2018.10.079","volume":"58","author":"R Kim","year":"2018","unstructured":"Kim, R. et al. Peripheral blood inflammatory markers in early Parkinson\u2019s disease. J. Clin. Neurosci. 58, 30\u201333 (2018).","journal-title":"J. Clin. Neurosci."},{"key":"184_CR14","doi-asserted-by":"crossref","unstructured":"Phillips, C. M., Shivappa, N., H\u00e9bert, J. R. & Perry, I. J. Dietary inflammatory index and biomarkers of lipoprotein metabolism, inflammation and glucose homeostasis in adults. Nutrients 10, 1033 (2018).","DOI":"10.3390\/nu10081033"},{"key":"184_CR15","doi-asserted-by":"crossref","unstructured":"Malagelada, C. et al. Metabolomic signature of the postprandial experience. Neurogastroenterol. Motil. 30, e13447 (2018).","DOI":"10.1111\/nmo.13447"},{"key":"184_CR16","doi-asserted-by":"crossref","unstructured":"Llaurad\u00f3, G. et al. Specific nuclear magnetic resonance lipoprotein subclass profiles and central arterial stiffness in type 1 diabetes mellitus: a case control study. J. Clin. Med. 8, 1875 (2019).","DOI":"10.3390\/jcm8111875"},{"key":"184_CR17","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.3390\/ijms20133151","volume":"20","author":"J Girona","year":"2019","unstructured":"Girona, J. et al. HDL triglycerides: a new marker of metabolic and cardiovascular risk. Int. J. Mol. Sci. 20, 3151 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"184_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3390\/antiox8070213","volume":"8","author":"E Rodr\u00edguez-Tom\u00e0s","year":"2019","unstructured":"Rodr\u00edguez-Tom\u00e0s, E. et al. Serum Paraoxonase-1-related variables and lipoprotein profile in patients with lung or head and neck cancer: effect of radiotherapy. Antioxidants 8, 213 (2019).","journal-title":"Antioxidants"},{"key":"184_CR19","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.1021\/acs.jproteome.8b00411","volume":"17","author":"R Fuertes-Mart\u00edn","year":"2018","unstructured":"Fuertes-Mart\u00edn, R. et al. Characterization of 1H NMR plasma glycoproteins as a new strategy to identify inflammatory patterns in rheumatoid arthritis. J. Proteome Res. 17, 3730\u20133739 (2018).","journal-title":"J. Proteome Res."},{"key":"184_CR20","doi-asserted-by":"publisher","unstructured":"Fuertes-Martin, R. et al. Glycoprotein A and B height to weight ratios as obesity-independent novel biomarkers of low-grade chronic inflammation in women with polycystic ovary syndrome (PCOS). J. Proteome Res. https:\/\/doi.org\/10.1021\/acs.jproteome.9b00528 (2019).","DOI":"10.1021\/acs.jproteome.9b00528"},{"key":"184_CR21","unstructured":"Medina, A. & Schiaffino, A. Enquesta de salut de Catalunya. http:\/\/salutweb.gencat.cat\/ca\/el_departament\/estadistiques_sanitaries\/enquestes\/esca\/resultats_enquesta_salut_catalunya\/ (2018)."},{"key":"184_CR22","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/ana.22282","volume":"69","author":"RB Postuma","year":"2011","unstructured":"Postuma, R. B., Gagnon, J. F., Vendette, M., Desjardins, C. & Montplaisir, J. Y. Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder. Ann. Neurol. 69, 811\u2013818 (2011).","journal-title":"Ann. Neurol."},{"key":"184_CR23","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/ana.25026","volume":"82","author":"A Iranzo","year":"2017","unstructured":"Iranzo, A. et al. Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder. Ann. Neurol. 82, 419\u2013428 (2017).","journal-title":"Ann. Neurol."},{"key":"184_CR24","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.parkreldis.2020.05.017","volume":"75","author":"L Honeycutt","year":"2020","unstructured":"Honeycutt, L. et al. Pareidolias and cognition in isolated REM sleep behavior disorder. Parkinsonism Relat. Disord. 75, 76\u201379 (2020).","journal-title":"Parkinsonism Relat. Disord."},{"key":"184_CR25","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s00415-010-5864-1","volume":"258","author":"MM Unger","year":"2011","unstructured":"Unger, M. M. et al. Is there a difference in gastric emptying between Parkinson\u2019s disease patients under long-term L-dopa therapy with and without motor fluctuations? An analysis using the (13)C-acetate breath test. J. Neurol. 258, 982\u2013990 (2011).","journal-title":"J. Neurol."},{"key":"184_CR26","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1002\/elps.201800316","volume":"39","author":"X Dong","year":"2018","unstructured":"Dong, X. et al. LC\u2013MS\/MS glycomics of idiopathic rapid eye movement sleep behavior disorder. Electrophoresis 39, 3096\u20133103 (2018).","journal-title":"Electrophoresis"},{"key":"184_CR27","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.molmed.2008.06.002","volume":"14","author":"A Varki","year":"2008","unstructured":"Varki, A. Sialic acids in human health and disease. Trends Mol. Med. 14, 351\u2013360 (2008).","journal-title":"Trends Mol. Med."},{"key":"184_CR28","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/mas.21555","volume":"37","author":"Q Zhang","year":"2018","unstructured":"Zhang, Q., Li, Z., Wang, Y., Zheng, Q. & Li, J. Mass spectrometry for protein sialoglycosylation. Mass Spectrom. Rev. 37, 652\u2013680 (2018).","journal-title":"Mass Spectrom. Rev."},{"key":"184_CR29","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2337\/dc16-1569","volume":"40","author":"C Lorenzo","year":"2017","unstructured":"Lorenzo, C. et al. Novel protein glycan-derived markers of systemic inflammation and C-reactive protein in relation to glycemia, insulin resistance, and insulin secretion. Diabetes Care 40, 375\u2013382 (2017).","journal-title":"Diabetes Care"},{"key":"184_CR30","unstructured":"Fuertes Mart\u00edn, R. 1H-NMR glycoprotein analysis: an advanced approach for inflammatory diseases diagnosis. TDX (Tesis Dr. en Xarxa) (2021)."},{"key":"184_CR31","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1002\/mds.27841","volume":"34","author":"R Kim","year":"2019","unstructured":"Kim, R. et al. Peripheral blood inflammatory cytokines in idiopathic REM sleep behavior disorder. Mov. Disord. 34, 1739\u20131744 (2019).","journal-title":"Mov. Disord."},{"key":"184_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2020.09.041","volume":"81","author":"R Kim","year":"2020","unstructured":"Kim, R. et al. Serum TNF-\u03b1 and neurodegeneration in isolated REM sleep behavior disorder. Park. Relat. Disord. 81, 1\u20137 (2020).","journal-title":"Park. Relat. Disord."},{"key":"184_CR33","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.parkreldis.2020.07.017","volume":"78","author":"H Zhang","year":"2020","unstructured":"Zhang, H. et al. Plasma immune markers in an idiopathic REM sleep behavior disorder cohort. Park. Relat. Disord. 78, 145\u2013150 (2020).","journal-title":"Park. Relat. Disord."},{"key":"184_CR34","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1136\/jnnp-2017-317134","volume":"89","author":"E King","year":"2018","unstructured":"King, E. et al. Peripheral inflammation in prodromal Alzheimer\u2019s and Lewy body dementias. J. Neurol. Neurosurg. Psychiatry 89, 339\u2013345 (2018).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"184_CR35","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/brain\/awy265","volume":"141","author":"A Surendranathan","year":"2018","unstructured":"Surendranathan, A. et al. Early microglial activation and peripheral inflammation in dementia with Lewy bodies. Brain 141, 3415\u20133427 (2018).","journal-title":"Brain"},{"key":"184_CR36","first-page":"1060","volume":"21","author":"X-H Ding","year":"2017","unstructured":"Ding, X.-H. et al. The predictive value of baseline LDL-TG level on major adverse cardiovascular events in a followed up cohort population. Eur. Rev. Med. Pharmacol. Sci. 21, 1060\u20131064 (2017).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"184_CR37","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jacc.2018.04.050","volume":"72","author":"A Saeed","year":"2018","unstructured":"Saeed, A. et al. Remnant-like particle cholesterol, low-density lipoprotein triglycerides, and incident cardiovascular disease. J. Am. Coll. Cardiol. 72, 156\u2013169 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"184_CR38","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1161\/CIRCULATIONAHA.108.816181","volume":"119","author":"S Mora","year":"2009","unstructured":"Mora, S. et al. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation 119, 931\u2013939 (2009).","journal-title":"Circulation"},{"key":"184_CR39","unstructured":"American Academy of Sleep Medicine. International Classification of Sleep Disorders. Darien, IL: American Academy of Sleep Medicine. 3rd edn (2014)."},{"key":"184_CR40","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1194\/jlr.D050120","volume":"56","author":"R Mallol","year":"2015","unstructured":"Mallol, R. et al. Liposcale: a novel advanced lipoprotein test based on 2D diffusion-ordered 1H NMR spectroscopy. J. Lipid Res. 56, 737\u2013746 (2015).","journal-title":"J. Lipid Res."},{"key":"184_CR41","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1467-9868.2005.00503.x","volume":"67","author":"H Zou","year":"2005","unstructured":"Zou, H. & Hastie, T. Regularization and variable selection via the elastic net. J. R. Stat. Soc. Ser. B Stat. Methodol. 67, 301\u2013320 (2005).","journal-title":"J. R. Stat. Soc. Ser. B Stat. Methodol."},{"key":"184_CR42","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/S0895-4356(01)00341-9","volume":"54","author":"EW Steyerberg","year":"2001","unstructured":"Steyerberg, E. W. et al. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J. Clin. Epidemiol. 54, 774\u2013781 (2001).","journal-title":"J. Clin. Epidemiol."},{"key":"184_CR43","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. (2020). https:\/\/www.R-project.org\/."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-021-00184-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-021-00184-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-021-00184-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T21:51:43Z","timestamp":1670017903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-021-00184-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,13]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["184"],"URL":"https:\/\/doi.org\/10.1038\/s41531-021-00184-9","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,13]]},"assertion":[{"value":"31 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N.A. is stock owner of Biosfer Teslab, has a patent to commercialize the lipoprotein and protein glycosylation profiling described in the present manuscript, and a patent for an NMR method for lipoprotein characterization. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40"}}